Hypertension in the frail elderly

Journal of the American Society of Hypertension

Volumn 10, Issue 6, 2016, Pages 536-541

  Materson, Barry J ^a   Garcia Estrada, Manuel ^b   Preston, Richard A ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Nephrologist   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Drug treatment; elderly; frail; hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; COGNITION; COGNITIVE DEFECT; FRAIL ELDERLY; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; SURVIVOR; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; COMPLICATION; DAILY LIFE ACTIVITY; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PROCEDURES; QUESTIONNAIRE; RISK FACTOR; TREATMENT WITHDRAWAL; VERY ELDERLY; WALKING SPEED;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; COGNITIVE DYSFUNCTION; FRAIL ELDERLY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRECISION MEDICINE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; WALKING SPEED; WITHHOLDING TREATMENT;

EID: 84964317901     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.03.187     Document Type: Review

References (33)

1. 1 Table 1, Population 65 years and older by age and sex: 2000 and 2010. U. S. Census Bureau. Census 2000 summary File 1 and 2010 census summary File 1.
2. 2 Ortman, J.M., Velkoff, V.A., Hogan, H., An Aging Nation: The Older Population in the United States, Current Population Reports, P25–1140. 2014, U.S. Census Bureau, Washington, DC.
3. 3 Muller, M., Smolders, Y.M., de Leeuw, P.W., Stehouwer, C.D., Treatment of hypertension in the oldest old: a critical role for frailty?. Hypertension 63 (2014), 433–441.
4. 4 Fields, L.E., Burt, V.L., Cutler, J.A., Hughes, J., Rocella, E.J., Sorlie, P., The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44 (2004), 398–404.
5. 5 Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol 56A (2001), M146–M156.
6. 6 Morley, J.E., Malmstrom, T.K., Miller, D.K., A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 16 (2012), 601–608.
7. 7 Lopez, D., Flicker, L., Dobson, A., Validation of the FRAIL scare in a cohort of older Australian women. J Am Geriatr Soc 60 (2012), 171–173.
8. 8 Woo, J., Leung, J., Morley, J.E., Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 60 (2012), 1478–1486.
9. 9 Malmstrom, T.K., Miller, D.K., Morley, J.E., A comparison of four frailty models. J Am Geriatr Soc 62 (2014), 721–726.
10. 10 Theou, O., Brothers, T.D., Peña, F.G., Mitnitski, A., Rockwood, K., Identifying common characteristics of frailty across seven scales. J Am Geriatr Soc 62 (2014), 901–906.
11. 11 Morley, J.E., Vellas, B., Abellan van Kan, G., Anker, S.D., Bauer, J.M., Bernabei, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 14 (2013), 392–397.
12. 12 Odden, M.C., Peralta, C.A., Haan, M.N., Covinsky, K.E., Rethinking the association of high blood pressure with mortality in elderly adults. Arch Intern Med 172 (2012), 1162–1168.
13. 13 Goodwin, J.S., Gait speed. An important vital sign in old age. Arch Intern Med 172 (2012), 1168–1169.
14. 14 Agnoletti, D., Valbusa, F., Labat, C., Gautier, S., Mourad, J.-J., Benetos, A., on behalf of the PARTAGE study investigators. Evidence for a prognostic role of orthostatic hypertension on survival in a very old institutionalized population. Hypertension 67 (2016), 191–196.
15. 15 Beckett, N.S., Peters, R., Fletcher, A.E., Staessen, J.A., Liu, L., Dumitrascu, D., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008), 1887–1898.
16. 16 Jacobs, J.M., Stessman, J., Ein-Mor, E., Bursztyn, M., Hypertension and 5-year mortality among 85-year-olds: The Jerusalem Longitudinal Study. J Am Med Dir Assoc 13 (2012), 759.e1–759.e6.
17. 17 Bulpitt, C.J., Beckett, N., Peters, R., Staessen, J.A., Wang, J.G., Comsa, M., et al. Does white coat hypertension require treatment over age 80? Results of the Hypertension in the Very Elderly Trial ambulatory blood pressure side project. Hypertension 61 (2013), 89–94.
18. 18 Warwick, J., Falaschetti, E., Rockwood, K., Mitnitski, A., Thijs, L., Beckett, N., et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: and investigation of the impact of frailty upon treatment in the Hypertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med, 13, 2015, 78.
19. 19 Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al., for The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
20. 20 Cushman, W.C., Evans, G.W., Byington, R.P., Goff, D.C. Jr., Grimm, R.H. Jr., Cutler, J.A., et al., for the ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362 (2010), 1575–1585.
21. 21 Ettehad, D., Emdin, C.A., Kirin, A., Anderson, S.G., Callendar, T., Emberson, J., et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387 (2016), 957–967.
22. 22 Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B., Ninomiya, T., et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 387 (2016), 435–443.
23. 23 Aparicio, L.S., Thijs, L., Boggia, J., Jacobs, L., Barochiner, J., Odili, A.N., Defining thresholds for home blood pressure monitoring in octogenarians. Hypertension 66 (2015), 865–873.
24. 24 Barochiner, J., Aparicio, L.S., Cuffaro, P.E., Galarza, C.R., Marín, M.J., Alfie, J., et al. Home blood pressure profile in very elderly hypertensives: should we use the same thresholds as in younger patients?. J Am Soc Hypertens 9 (2015), 184–190.
25. 25 Materson, B.J., Cushman, W.C., Goldstein, G., Reda, D.J., the Veterans Administration Cooperative Study Group on Antihypertensive Agents. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 15 (1990), 348–360.
26. 26 Goldstein, G., Materson, B.J., Cushman, W.C., Reda, D.J., the Veterans Administration Cooperative Study Group on Antihypertensive Agents. Treatment of hypertension in the elderly. II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 15 (1990), 361–369.
27. 27 Mosello, E., Pieracciolo, M., Nesti, N., Bulgaresi, M., Lorenzi, C., Caleri, V., et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 175 (2015), 578–585.
28. 28 Benetos, A., Labat, C., Rossignol, P., Fay, R., Rolland, Y., Valbusa, F., et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents. The PARTAGE Study. JAMA Intern Med 175 (2015), 989–995.
29. 29 Benetos, A., Rossignol, P., Cherubini, A., Joly, L., Grodzicki, T., Rajkumar, C., et al. Polypharmacy in the aging patient. Management of hypertension in octogenarians. JAMA 314 (2015), 170–180.
30. 30 Foster-Dingley, J.C., Moonen, J.E., de Craen, A.J., de Ruijter, W., van der Mast, R.C., van der Grond, J., Blood pressure is not associated with cerebral blood flow in older persons. Hypertension 66 (2015), 954–960.
31. 31 Lipsitz, L.A., Habtemariam, D., Gagnon, M., Iloputaife, I., Sorond, F., Tchalla, A.E., et al. Reexamining the effect of antihypertensive medications on falls in old age. Hypertension 66 (2015), 183–189.
32. 32 Gottesman, R.F., Schneider, A.L., Albert, M., Alonso, A., Bandeen-Roche, K., Coker, L., et al. Midlife hypertension and 20-year cognitive change. The Atherosclerosis Risk in Communities Neurocognitive Study. JAMA Neurol 71 (2014), 1218–1227.
33. 33 Materson, B.J., Wright, C.B., Goal blood pressure for cognition-impaired patients: let's treat the patients—not the numbers. J Am Soc Hypertens 9 (2015), 504–506.